Staiger, Harald

Association of the T-G Polymorphism in Adiponectin (Exon 2) With Obesity and Insulin Sensitivity

Stumvoll, M., Tschritter, O., Fritsche, A., Staiger, H., Renn, W., Weisser, M., Machicao, F., & Häring, H. (2002) · Diabetes

Adipokines, Inflammation, and Metabolic DiseasesGenetic Associations and Epidemiology

Cited by 371

Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production

Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE

Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Cited by 282

Fibroblast Growth Factor 21—Metabolic Role in Mice and Men

Staiger, H., Keuper, M., Berti, L., Hrabě de Angelis, M., & Häring, H.-U. (2017) · Endocrine Reviews

Fibroblast Growth Factor ResearchAdipokines, Inflammation, and Metabolic Diseases

Cited by 270

Palmitate, but Not Unsaturated Fatty Acids, Induces the Expression of Interleukin-6 in Human Myotubes through Proteasome-dependent Activation of Nuclear Factor-κB

Weigert, C., Brodbeck, K., Staiger, H., Kausch, C., Machicao, F., Häring, H. U., & Schleicher, E. D. (2004) · Journal of Biological Chemistry

Adipokines, Inflammation, and Metabolic DiseasesCytokine Signaling Pathways and Interactions

Cited by 269

Muscle-Derived Angiopoietin-Like Protein 4 Is Induced by Fatty Acids via Peroxisome Proliferator–Activated Receptor (PPAR)-δ and Is of Metabolic Relevance in Humans

Staiger, H., Haas, C., Machann, J., Werner, R., Weisser, M., Schick, F., Machicao, F., Stefan, N., Fritsche, A., & Häring, H.-U. (2009) · Diabetes

Peroxisome Proliferator-Activated ReceptorsLipid metabolism and disorders

Cited by 183

Cytokine response of primary human myotubes in an in vitro exercise model

Scheler, M., Irmler, M., Lehr, S., Hartwig, S., Staiger, H., Al-Hasani, H., Beckers, J., Hrabé de Angelis, M., Häring, H.-U., & Weigert, C. (2013) · American Journal of Physiology-Cell Physiology

Exercise and Physiological ResponsesMuscle Physiology and Disorders

Cited by 123

Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial

Kantartzis, K., Fritsche, L., Bombrich, M., Machann, J., Schick, F., Staiger, H., Kunz, I., Schoop, R., Lehn‐Stefan, A., Heni, M., et al. (2018) · Diabetes, Obesity and Metabolism

Sirtuins and Resveratrol in MedicineLiver Disease Diagnosis and Treatment

Cited by 87

Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

Berti, L., Irmler, M., Zdichavsky, M., Meile, T., Böhm, A., Stefan, N., Fritsche, A., Beckers, J., Königsrainer, A., Häring, H.-U., et al. (2015) · Molecular Metabolism

Fibroblast Growth Factor ResearchAdipokines, Inflammation, and Metabolic Diseases

Cited by 73

Glucose-Raising Genetic Variants in MADD and ADCY5 Impair Conversion of Proinsulin to Insulin

Wagner, R., Dudziak, K., Herzberg-Schäfer, S. A., Machicao, F., Stefan, N., Staiger, H., Häring, H.-U., & Fritsche, A. (2011) · PLoS ONE

Pancreatic function and diabetesGenetic Associations and Epidemiology

Cited by 50

Genetic variants in MTNR1B affecting insulin secretion

Müssig, K., Staiger, H., Machicao, F., Häring, H.-U., & Fritsche, A. (2010) · Annals of Medicine

Circadian rhythm and melatoninPancreatic function and diabetes

Cited by 38

Common variation in the sodium/glucose cotransporter 2 gene SLC5A2 does neither affect fasting nor glucose-suppressed plasma glucagon concentrations

Ordelheide, A.-M., Böhm, A., Kempe-Teufel, D., Wagner, R., Machicao, F., Heni, M., Stefan, N., Fritsche, A., Häring, H.-U., & Staiger, H. (2017) · PLOS ONE

Diabetes Treatment and ManagementGenetic Associations and Epidemiology

Cited by 14